Advertisement

Human Genetics

, Volume 122, Issue 1, pp 1–21 | Cite as

Molecular genetics of human growth hormone, insulin-like growth factors and their pathways in common disease

  • Santiago RodriguezEmail author
  • Tom R. Gaunt
  • Ian N. M. Day
Review

Abstract

The human growth hormone gene (GH1) and the insulin-like growth factor 1 and 2 genes (IGF1 and IGF2) encode the central elements of a key pathway influencing growth in humans. This “growth pathway” also includes transcription factors, agonists, antagonists, receptors, binding proteins, and endocrine factors that constitute an intrincate network of feedback loops. GH1 is evolutionarily coupled with other genes in linkage disequilibrium in 17q24.2, and the same applies to IGF2 in 11p15.5. In contrast, IGF1 in 12q22-24.1 is not in strong linkage disequilibrium with neighbouring genes. Knowledge of the functional architecture of these regions is important for the understanding of the combined evolution and function of GH1, IGF2 and IGF1 in relation to complex diseases. A number of mutations accounting for rare Mendelian disorders have been described in GH-IGF elements. The constellation of genes in this key pathway contains potential candidates in a number of complex diseases, including growth disorders, metabolic syndrome, diabetes (notably IGF2BP2) cardiovascular disease, and central nervous system diseases, and in longevity, aging and cancer. We review these genes and their associations with disease phenotypes, with special attention to metabolic risk traits.

Keywords

Growth Hormone Tyrosine Hydroxylase Growth Hormone Deficiency Locus Control Region Mechano Growth Factor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgments

We thank three anonymous reviewers for their helpful comments. Work in our laboratory has been funded by UK MRC and British Heart Foundation, also by University of Bristol, UK. TRG is funded by a BHF (British Heart Foundation) Intermediate Fellowship (FS/05/065/19497).

Supplementary material

References

  1. Aberg ND, Brywe KG, Isgaard J (2006) Aspects of growth hormone and insulin-like growth factor-I related to neuroprotection, regeneration, and functional plasticity in the adult brain. ScientificWorldJournal 6:53–80PubMedCrossRefGoogle Scholar
  2. Abuzzahab MJ, Schneider A, Goddard A, Grigorescu F, Lautier C, Keller E, Kiess W, Klammt J, Kratzsch J, Osgood D, Pfaffle R, Raile K, Seidel B, Smith RJ, Chernausek SD (2003) IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation. N Engl J Med 349:2211–2222PubMedCrossRefGoogle Scholar
  3. Ahluwalia A, Clodfelter KH, Waxman DJ (2004) Sexual dimorphism of rat liver gene expression: regulatory role of growth hormone revealed by deoxyribonucleic acid microarray analysis. Mol Endocrinol 18:747–760PubMedCrossRefGoogle Scholar
  4. Al-Zahrani A, Sandhu MS, Luben RN, Thompson D, Baynes C, Pooley KA, Luccarini C, Munday H, Perkins B, Smith P, Pharoah PD, Wareham NJ, Easton DF, Ponder BA, Dunning AM (2006) IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer. Hum Mol Genet 15:1–10PubMedCrossRefGoogle Scholar
  5. Albanese V, Biguet NF, Kiefer H, Bayard E, Mallet J, Meloni R (2001) Quantitative effects on gene silencing by allelic variation at a tetranucleotide microsatellite. Hum Mol Genet 10:1785–1792PubMedCrossRefGoogle Scholar
  6. Alharbi KK, Aldahmesh MA, Spanakis E, Haddad L, Whittall RA, Chen XH, Rassoulian H, Smith MJ, Sillibourne J, Ball NJ, Graham NJ, Briggs PJ, Simpson IA, Phillips DI, Lawlor DA, Ye S, Humphries SE, Cooper C, Smith GD, Ebrahim S, Eccles DM, Day IN (2005) Mutation scanning by meltMADGE: validations using BRCA1 and LDLR, and demonstration of the potential to identify severe, moderate, silent, rare, and paucimorphic mutations in the general population. Genome Res 15:967–977PubMedCrossRefGoogle Scholar
  7. Alharbi KK, Spanakis E, Tan K, Smith MJ, Aldahmesh MA, O’Dell SD, Sayer AA, Lawlor DA, Ebrahim S, Smith GD, O’Rahilly S, Farooqi S, Cooper C, Phillips DI, Day IN (2006) Prevalence and functionality of paucimorphic and private MC4R mutations in a large, unselected European British population, scanned by meltMADGE. Hum Mutat (in press)Google Scholar
  8. Amit T, Youdim MB, Hochberg Z (2000) Clinical review 112: does serum growth hormone (GH) binding protein reflect human GH receptor function? J Clin Endocrinol Metab 85:927–932PubMedCrossRefGoogle Scholar
  9. Asakawa A, Inui A, Kaga T, Yuzuriha H, Nagata T, Ueno N, Makino S, Fujimiya M, Niijima A, Fujino MA, Kasuga M (2001) Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology 120:337–345PubMedCrossRefGoogle Scholar
  10. Baas AF, Boudeau J, Sapkota GP, Smit L, Medema R, Morrice NA, Alessi DR, Clevers HC (2003) Activation of the tumour suppressor kinase LKB1 by the STE20-like pseudokinase STRAD. EMBO J 22:3062–3072PubMedCrossRefGoogle Scholar
  11. Ballare E, Persani L, Lania AG, Filopanti M, Giammona E, Corbetta S, Mantovani S, Arosio M, Beck-Peccoz P, Faglia G, Spada A (2001) Mutation of somatostatin receptor type 5 in an acromegalic patient resistant to somatostatin analog treatment. J Clin Endocrinol Metab 86:3809–3814PubMedCrossRefGoogle Scholar
  12. Barbieri M, Bonafe M, Franceschi C, Paolisso G (2003a) Insulin/IGF-I-signaling pathway: an evolutionarily conserved mechanism of longevity from yeast to humans. Am J Physiol Endocrinol Metab 285:E1064–E1071PubMedGoogle Scholar
  13. Barbieri M, Ferrucci L, Ragno E, Corsi A, Bandinelli S, Bonafe M, Olivieri F, Giovagnetti S, Franceschi C, Guralnik JM, Paolisso G (2003b) Chronic inflammation and the effect of IGF-I on muscle strength and power in older persons. Am J Physiol Endocrinol Metab 284:E481–E487PubMedGoogle Scholar
  14. Barratt BJ, Payne F, Lowe CE, Hermann R, Healy BC, Harold D, Concannon P, Gharani N, McCarthy MI, Olavesen MG, McCormack R, Guja C, Ionescu-Tirgoviste C, Undlien DE, Ronningen KS, Gillespie KM, Tuomilehto-Wolf E, Tuomilehto J, Bennett ST, Clayton DG, Cordell HJ, Todd JA (2004) Remapping the insulin gene/IDDM2 locus in type 1 diabetes. Diabetes 53:1884–1889PubMedCrossRefGoogle Scholar
  15. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263–265PubMedCrossRefGoogle Scholar
  16. Bartke A (2005) Minireview: role of the growth hormone/insulin-like growth factor system in mammalian aging. Endocrinology 146:3718–3723PubMedCrossRefGoogle Scholar
  17. Barton ER (2006) The ABCs of IGF-I isoforms: impact on muscle hypertrophy and implications for repair. Appl Physiol Nutr Metab 31:791–797PubMedCrossRefGoogle Scholar
  18. Barton PJ, Felkin LE, Birks EJ, Cullen ME, Banner NR, Grindle S, Hall JL, Miller LW, Yacoub MH (2005) Myocardial insulin-like growth factor-I gene expression during recovery from heart failure after combined left ventricular assist device and clenbuterol therapy. Circulation 112:I46–I50PubMedGoogle Scholar
  19. Bauer CK, Wulfsen I, Schafer R, Glassmeier G, Wimmers S, Flitsch J, Ludecke DK, Schwarz JR (2003) HERG K(+) currents in human prolactin-secreting adenoma cells. Pflugers Arch 445:589–600PubMedGoogle Scholar
  20. Bell AC, Felsenfeld G (2000) Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene. Nature 405:482–485PubMedCrossRefGoogle Scholar
  21. Bennett ST, Todd JA (1996) Human type 1 diabetes and the insulin gene: principles of mapping polygenes. Annu Rev Genet 30:343–370PubMedCrossRefGoogle Scholar
  22. Besson A, Salemi S, Gallati S, Jenal A, Horn R, Mullis PS, Mullis PE (2003) Reduced longevity in untreated patients with isolated growth hormone deficiency. J Clin Endocrinol Metab 88:3664–3667PubMedCrossRefGoogle Scholar
  23. Binder G, Baur F, Schweizer R, Ranke MB (2006) The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-for-gestational-age children. J Clin Endocrinol Metab 91:659–664PubMedCrossRefGoogle Scholar
  24. Bleumink GS, Schut AF, Sturkenboom MC, Janssen JA, Witteman JC, van Duijn CM, Hofman A, Stricker BH (2005) A promoter polymorphism of the insulin-like growth factor-I gene is associated with left ventricular hypertrophy. Heart 91:239–240PubMedCrossRefGoogle Scholar
  25. Bodner M, Karin M (1987) A pituitary-specific trans-acting factor can stimulate transcription from the growth hormone promoter in extracts of nonexpressing cells. Cell 50:267–275PubMedCrossRefGoogle Scholar
  26. Bonafe M, Barbieri M, Marchegiani F, Olivieri F, Ragno E, Giampieri C, Mugianesi E, Centurelli M, Franceschi C, Paolisso G (2003) Polymorphic variants of insulin-like growth factor I (IGF-I) receptor and phosphoinositide 3-kinase genes affect IGF-I plasma levels and human longevity: cues for an evolutionarily conserved mechanism of life span control. J Clin Endocrinol Metab 88:3299–3304PubMedCrossRefGoogle Scholar
  27. Bonapace G, Concolino D, Formicola S, Strisciuglio P (2003) A novel mutation in a patient with insulin-like growth factor 1 (IGF1) deficiency. J Med Genet 40:913–917PubMedCrossRefGoogle Scholar
  28. Bulow B, Hagmar L, Mikoczy Z, Nordstrom CH, Erfurth EM (1997) Increased cerebrovascular mortality in patients with hypopituitarism. Clin Endocrinol (Oxf) 46:75–81CrossRefGoogle Scholar
  29. Butler AA, Le RD (2001) Control of growth by the somatropic axis: growth hormone and the insulin-like growth factors have related and independent roles. Annu Rev Physiol 63:141–164PubMedCrossRefGoogle Scholar
  30. Canzian F, McKay JD, Cleveland RJ, Dossus L, Biessy C, Boillot C, Rinaldi S, Llewellyn M, Chajes V, Clavel-Chapelon F, Tehard B, Chang-Claude J, Linseisen J, Lahmann PH, Pischon T, Trichopoulos D, Trichopoulou A, Zilis D, Palli D, Tumino R, Vineis P, Berrino F, Bueno-de-Mesquita HB, van Gils CH, Peeters PH, Pera G, Barricarte A, Chirlaque MD, Quiros JR, Larranaga N, Martinez-Garcia C, Allen NE, Key TJ, Bingham SA, Khaw KT, Slimani N, Norat T, Riboli E, Kaaks R (2005) Genetic variation in the growth hormone synthesis pathway in relation to circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3, and breast cancer risk: results from the European prospective investigation into cancer and nutrition study. Cancer Epidemiol Biomarkers Prev 14:2316–2325PubMedCrossRefGoogle Scholar
  31. Carling D (2004) The AMP-activated protein kinase cascade—a unifying system for energy control. Trends Biochem Sci 29:18–24PubMedCrossRefGoogle Scholar
  32. Castro-Feijoo L, Quinteiro C, Loidi L, Barreiro J, Cabanas P, Arevalo T, Dieguez C, Casanueva FF, Pombo M (2005) Genetic basis of short stature. J Endocrinol Invest 28:30–37PubMedGoogle Scholar
  33. Ceda GP, Dall’Aglio E, Maggio M, Lauretani F, Bandinelli S, Falzoi C, Grimaldi W, Ceresini G, Corradi F, Ferrucci L, Valenti G, Hoffman AR (2005) Clinical implications of the reduced activity of the GH-IGF-I axis in older men. J Endocrinol Invest 28:96–100PubMedGoogle Scholar
  34. Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P, Hennekens CH, Pollak M (1998) Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 279:563–566PubMedCrossRefGoogle Scholar
  35. Chen EY, Liao YC, Smith DH, Barrera-Saldana HA, Gelinas RE, Seeburg PH (1989) The human growth hormone locus: nucleotide sequence, biology, and evolution. Genomics 4:479–497PubMedCrossRefGoogle Scholar
  36. Chen JM, Ferec C, Cooper DN (2006) A systematic analysis of disease-associated variants in the 3′ regulatory regions of human protein-coding genes II: the importance of mRNA secondary structure in assessing the functionality of 3′ UTR variants. Hum Genet 120:301–333PubMedCrossRefGoogle Scholar
  37. Christiansen J, Kofod M, Nielsen FC (1994) A guanosine quadruplex and two stable hairpins flank a major cleavage site in insulin-like growth factor II mRNA. Nucleic Acids Res 22:5709–5716PubMedCrossRefGoogle Scholar
  38. Clodfelter KH, Holloway MG, Hodor P, Park SH, Ray WJ, Waxman DJ (2006) Sex-dependent liver gene expression is extensive and largely dependent upon signal transducer and activator of transcription 5b (STAT5b): STAT5b-dependent activation of male genes and repression of female genes revealed by microarray analysis. Mol Endocrinol 20:1333–1351PubMedCrossRefGoogle Scholar
  39. Cogan, Phillips JA (2001) Inherited defects in growth hormone synthesis and action. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Kinzler KW, Vogelstein B (eds) The metabolic and molecular bases of inherited disease, 8th edn. McGraw-Hill, New York, pp 4159–4180Google Scholar
  40. Cohen RN, Cohen LE, Botero D, Yu C, Sagar A, Jurkiewicz M, Radovick S (2003) Enhanced repression by HESX1 as a cause of hypopituitarism and septooptic dysplasia. J Clin Endocrinol Metab 88:4832–4839PubMedCrossRefGoogle Scholar
  41. Colao A, di SC, Pivonello R, Cuocolo A, Spinelli L, Bonaduce D, Salvatore M, Lombardi G (2002) The cardiovascular risk of adult GH deficiency (GHD) improved after GH replacement and worsened in untreated GHD: a 12-month prospective study. J Clin Endocrinol Metab 87:1088–1093PubMedCrossRefGoogle Scholar
  42. Constancia M, Dean W, Lopes S, Moore T, Kelsey G, Reik W (2000) Deletion of a silencer element in Igf2 results in loss of imprinting independent of H19. Nat Genet 26:203–206PubMedCrossRefGoogle Scholar
  43. Conti E, Carrozza C, Capoluongo E, Volpe M, Crea F, Zuppi C, Andreotti F (2004) Insulin-like growth factor-1 as a vascular protective factor. Circulation 110:2260–2265PubMedCrossRefGoogle Scholar
  44. Crisan D, Carr J (2000) Angiotensin I-converting enzyme: genotype and disease associations. J Mol Diagn 2:105–115PubMedGoogle Scholar
  45. Cummings DE, Merriam GR (2003) Growth hormone therapy in adults. Annu Rev Med 54:513–533PubMedCrossRefGoogle Scholar
  46. Cummings DE, Schwartz MW (2003) Genetics and pathophysiology of human obesity. Annu Rev Med 54:453–471PubMedCrossRefGoogle Scholar
  47. Cummings DE, Clement K, Purnell JQ, Vaisse C, Foster KE, Frayo RS, Schwartz MW, Basdevant A, Weigle DS (2002a) Elevated plasma ghrelin levels in Prader Willi syndrome. Nat Med 8:643–644PubMedCrossRefGoogle Scholar
  48. Cummings DE, Weigle DS, Frayo RS, Breen PA, Ma MK, Dellinger EP, Purnell JQ (2002b) Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 346:1623–1630PubMedCrossRefGoogle Scholar
  49. Cuneo RC, Judd S, Wallace JD, Perry-Keene D, Burger H, Lim-Tio S, Strauss B, Stockigt J, Topliss D, Alford F, Hew L, Bode H, Conway A, Handelsman D, Dunn S, Boyages S, Cheung NW, Hurley D (1998) The Australian multicenter trial of growth hormone (GH) treatment in GH-deficient adults. J Clin Endocrinol Metab 83:107–116PubMedCrossRefGoogle Scholar
  50. Da Costa TH, Williamson DH, Ward A, Bates P, Fisher R, Richardson L, Hill DJ, Robinson IC, Graham CF (1994) High plasma insulin-like growth factor-II and low lipid content in transgenic mice: measurements of lipid metabolism. J Endocrinol 143:433–439PubMedGoogle Scholar
  51. Day IN, King TH, Chen XH, Voropanov AM, Ye S, Syddall HE, Sayer AA, Cooper C, Barker DJ, Phillips DI (2002) Insulin-like growth factor-I genotype and birthweight. Lancet 360:945–946PubMedCrossRefGoogle Scholar
  52. Day IN, Chen XH, Gaunt TR, King TH, Voropanov A, Ye S, Rodriguez S, Syddall HE, Sayer AA, Dennison EM, Tabassum F, Barker DJ, Cooper C, Phillips DI (2004a) Late life metabolic syndrome, early growth, and common polymorphism in the growth hormone and placental lactogen gene cluster. J Clin Endocrinol Metab 89:5569–5576PubMedCrossRefGoogle Scholar
  53. Day INM, Al-Harbi K, Smith M, Al Dahmesh M, Zhang B, Lotery A, Cross NCP, Ye S, Eccles D, Fox K, Rodríguez S (2004b) Paucimorphic alleles versus polymorphic alleles in disease causation: theory, observation and detection. Curr Genomics 5:431–438CrossRefGoogle Scholar
  54. de la Monte SM, Wands JR (2005) Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer’s disease. J Alzheimers Dis 7:45–61Google Scholar
  55. DelParigi A, Tschop M, Heiman ML, Salbe AD, Vozarova B, Sell SM, Bunt JC, Tataranni PA (2002) High circulating ghrelin: a potential cause for hyperphagia and obesity in prader-willi syndrome. J Clin Endocrinol Metab 87:5461–5464PubMedCrossRefGoogle Scholar
  56. Dennison EM, Syddall HE, Rodriguez S, Voropanov A, Day IN, Cooper C (2004) Polymorphism in the growth hormone gene, weight in infancy, and adult bone mass. J Clin Endocrinol Metab 89:4898–4903PubMedCrossRefGoogle Scholar
  57. Domene HM, Bengolea SV, Martinez AS, Ropelato MG, Pennisi P, Scaglia P, Heinrich JJ, Jasper HG (2004) Deficiency of the circulating insulin-like growth factor system associated with inactivation of the acid-labile subunit gene. N Engl J Med 350:570–577PubMedCrossRefGoogle Scholar
  58. DosSantos C, Essioux L, Teinturier C, Tauber M, Goffin V, Bougneres P (2004) A common polymorphism of the growth hormone receptor is associated with increased responsiveness to growth hormone. Nat Genet 36:720–724CrossRefGoogle Scholar
  59. Dunger DB, Petry CJ, Ong KK (2006) Genetic variations and normal fetal growth. Horm Res 65(Suppl 3):34–40PubMedCrossRefGoogle Scholar
  60. Ewald H, Mors O, Flint T, Koed K, Eiberg H, Kruse TA (1995) A possible locus for manic depressive illness on chromosome 16p13. Psychiatr Genet 5:71–81PubMedCrossRefGoogle Scholar
  61. Farrall M (2004) Quantitative genetic variation: a post-modern view. Hum Mol Genet 13 Spec No 1:R1–R7Google Scholar
  62. Feinberg (2001) Genome imprinting and cancer. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Kinzler KW, Vogelstein B (eds) The metabolic and molecular bases of inherited disease, 8th edn. McGraw-Hill, New York, pp 525–537Google Scholar
  63. Flores-Morales A, Greenhalgh CJ, Norstedt G, Rico-Bautista E (2006) Negative regulation of growth hormone receptor signaling. Mol Endocrinol 20:241–253PubMedCrossRefGoogle Scholar
  64. Franceschi C, Olivieri F, Marchegiani F, Cardelli M, Cavallone L, Capri M, Salvioli S, Valensin S, De BG, Di IA, Caruso C, Paolisso G, Monti D (2005) Genes involved in immune response/inflammation, IGF1/insulin pathway and response to oxidative stress play a major role in the genetics of human longevity: the lesson of centenarians. Mech Ageing Dev 126:351–361PubMedCrossRefGoogle Scholar
  65. Franco C, Brandberg J, Lonn L, Andersson B, Bengtsson BA, Johannsson G (2005) Growth hormone treatment reduces abdominal visceral fat in postmenopausal women with abdominal obesity: a 12-month placebo-controlled trial. J Clin Endocrinol Metab 90:1466–1474PubMedCrossRefGoogle Scholar
  66. Frayling TM, Hattersley AT, McCarthy A, Holly J, Mitchell SM, Gloyn AL, Owen K, Davies D, Smith GD, Ben-Shlomo Y (2002) A putative functional polymorphism in the IGF-I gene: association studies with type 2 diabetes, adult height, glucose tolerance, and fetal growth in UK populations. Diabetes 51:2313–2316PubMedCrossRefGoogle Scholar
  67. Freeth JS, Ayling RM, Whatmore AJ, Towner P, Price DA, Norman MR, Clayton PE (1997) Human skin fibroblasts as a model of growth hormone (GH) action in GH receptor-positive Laron’s syndrome. Endocrinology 138:55–61PubMedCrossRefGoogle Scholar
  68. Gasparini L, Xu H (2003) Potential roles of insulin and IGF-1 in Alzheimer’s disease. Trends Neurosci 26:404–406PubMedCrossRefGoogle Scholar
  69. Gaunt TR, Cooper JA, Miller GJ, Day IN, O’Dell SD (2001) Positive associations between single nucleotide polymorphisms in the IGF2 gene region and body mass index in adult males. Hum Mol Genet 10:1491–1501PubMedCrossRefGoogle Scholar
  70. Gicquel C, Le BY (2006) Hormonal regulation of fetal growth. Horm Res 65(Suppl 3):28–33PubMedCrossRefGoogle Scholar
  71. Giordano M, Marchetti C, Chiorboli E, Bona G, Momigliano RP (1997) Evidence for gene conversion in the generation of extensive polymorphism in the promoter of the growth hormone gene. Hum Genet 100:249–255PubMedCrossRefGoogle Scholar
  72. Goddard AD, Covello R, Luoh SM, Clackson T, Attie KM, Gesundheit N, Rundle AC, Wells JA, Carlsson LM (1995) Mutations of the growth hormone receptor in children with idiopathic short stature. The Growth Hormone Insensitivity Study Group. N Engl J Med 333:1093–1098PubMedCrossRefGoogle Scholar
  73. Goldspink G (2006) Impairment of IGF-I gene splicing and MGF expression associated with muscle wasting. Int J Biochem Cell Biol 38:481–489PubMedCrossRefGoogle Scholar
  74. Gourmelen M, Le BY, Girard F, Binoux M (1984) Serum levels of insulin-like growth factor (IGF) and IGF binding protein in constitutionally tall children and adolescents. J Clin Endocrinol Metab 59:1197–1203PubMedCrossRefGoogle Scholar
  75. Gray SG, Kjellman M, Larsson C, Ekstrom TJ (1997) Novel splicing of an IGF2 polymorphic region in human adrenocortical carcinomas. Biochem Biophys Res Commun 239:878–883PubMedCrossRefGoogle Scholar
  76. Gu D, O' Dell SD, Chen XH, Miller GJ, Day IN (2002) Evidence of multiple causal sites affecting weight in the IGF2-INS-TH region of human chromosome 11. Hum Genet 110:173–181PubMedCrossRefGoogle Scholar
  77. Gunnell D, Lewis S, Wilkinson J, Georgieva L, Davey GS, Day IN, Holly JM, O’Donovan MC, Owen MJ, Kirov G, Zammit S (2007) IGF1, growth pathway polymorphisms and schizophrenia: a pooling study. Am J Med Genet B Neuropsychiatr Genet 144:117–120PubMedGoogle Scholar
  78. Handwerger S, Freemark M (2000) The roles of placental growth hormone and placental lactogen in the regulation of human fetal growth and development. J Pediatr Endocrinol Metab 13:343–356PubMedGoogle Scholar
  79. Hark AT, Schoenherr CJ, Katz DJ, Ingram RS, Levorse JM, Tilghman SM (2000) CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus. Nature 405:486–489PubMedCrossRefGoogle Scholar
  80. Hasdai D, Rizza RA, Holmes DR Jr, Richardson DM, Cohen P, Lerman A (1998) Insulin and insulin-like growth factor-I cause coronary vasorelaxation in vitro. Hypertension 32:228–234PubMedGoogle Scholar
  81. Hasegawa Y, Fujii K, Yamada M, Igarashi Y, Tachibana K, Tanaka T, Onigata K, Nishi Y, Kato S, Hasegawa T (2000) Identification of novel human GH-1 gene polymorphisms that are associated with growth hormone secretion and height. J Clin Endocrinol Metab 85:1290–1295PubMedCrossRefGoogle Scholar
  82. Heald A, Stephens R, Gibson JM (2006a) The insulin-like growth factor system and diabetes–an overview. Diabet Med 23(Suppl 1):19–24PubMedCrossRefGoogle Scholar
  83. Heald AH, Karvestedt L, Anderson SG, McLaughlin J, Knowles A, Wong L, Grill V, Cruickshank JK, White A, Gibson JM, Brismar K (2006b) Low insulin-like growth factor-II levels predict weight gain in normal weight subjects with type 2 diabetes. Am J Med 119:167e 9–15CrossRefGoogle Scholar
  84. Hinney A, Hoch A, Geller F, Schafer H, Siegfried W, Goldschmidt H, Remschmidt H, Hebebrand J (2002a) Ghrelin gene: identification of missense variants and a frameshift mutation in extremely obese children and adolescents and healthy normal weight students. J Clin Endocrinol Metab 87:2716PubMedCrossRefGoogle Scholar
  85. Hinney A, Hoch A, Geller F, Schafer H, Siegfried W, Goldschmidt H, Remschmidt H, Hebebrand J (2002b) Ghrelin gene: identification of Missense variants and a frameshift mutation in extremely obese children and adolescents and healthy normal weight students. J Clin Endocrinol Metab 87:2716PubMedCrossRefGoogle Scholar
  86. Ho Y, Elefant F, Cooke N, Liebhaber S (2002) A defined locus control region determinant links chromatin domain acetylation with long-range gene activation. Mol Cell 9:291–302PubMedCrossRefGoogle Scholar
  87. Holzenberger M, Dupont J, Ducos B, Leneuve P, Geloen A, Even PC, Cervera P, Le BY (2003) IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature 421:182–187PubMedCrossRefGoogle Scholar
  88. Horan M, Millar DS, Hedderich J, Lewis G, Newsway V, Mo N, Fryklund L, Procter AM, Krawczak M, Cooper DN (2003) Human growth hormone 1 (GH1) gene expression: complex haplotype-dependent influence of polymorphic variation in the proximal promoter and locus control region. Hum Mutat 21:408–423PubMedCrossRefGoogle Scholar
  89. Horan M, Newsway V, Yasmin, Lewis MD, Easter TE, Rees DA, Mahto A, Millar DS, Procter AM, Scanlon MF, Wilkinson IB, Hall IP, Wheatley A, Blakey J, Bath PM, Cockcroft JR, Krawczak M, Cooper DN (2006) Genetic variation at the growth hormone (GH1) and growth hormone receptor (GHR) loci as a risk factor for hypertension and stroke. Hum Genet 119:527–540PubMedCrossRefGoogle Scholar
  90. Hubbard T, Andrews D, Caccamo M, Cameron G, Chen Y, Clamp M, Clarke L, Coates G, Cox T, Cunningham F, Curwen V, Cutts T, Down T, Durbin R, Fernandez-Suarez XM, Gilbert J, Hammond M, Herrero J, Hotz H, Howe K, Iyer V, Jekosch K, Kahari A, Kasprzyk A, Keefe D, Keenan S, Kokocinsci F, London D, Longden I, McVicker G, Melsopp C, Meidl P, Potter S, Proctor G, Rae M, Rios D, Schuster M, Searle S, Severin J, Slater G, Smedley D, Smith J, Spooner W, Stabenau A, Stalker J, Storey R, Trevanion S, Ureta-Vidal A, Vogel J, White S, Woodwark C, Birney E (2005) Ensembl 2005. Nucleic Acids Res 33:D447–D453PubMedCrossRefGoogle Scholar
  91. Iida K, Takahashi Y, Kaji H, Takahashi MO, Okimura Y, Nose O, Abe H, Chihara K (1999) Functional characterization of truncated growth hormone (GH) receptor-(1–277) causing partial GH insensitivity syndrome with high GH-binding protein. J Clin Endocrinol Metab 84:1011–1016PubMedCrossRefGoogle Scholar
  92. Izhar U, Hasdai D, Richardson DM, Cohen P, Lerman A (2000) Insulin and insulin-like growth factor-I cause vasorelaxation in human vessels in vitro. Coron Artery Dis 11:69–76PubMedCrossRefGoogle Scholar
  93. Jansen E, Steenbergh PH, van Schaik FM, Sussenbach JS (1992) The human IGF-I gene contains two cell type-specifically regulated promoters. Biochem Biophys Res Commun 187:1219–1226PubMedCrossRefGoogle Scholar
  94. Jenkins PJ, Mukherjee A, Shalet SM (2006) Does growth hormone cause cancer? Clin Endocrinol (Oxf) 64:115–121CrossRefGoogle Scholar
  95. Jeon JT, Carlborg O, Tornsten A, Giuffra E, Amarger V, Chardon P, Andersson-Eklund L, Andersson K, Hansson I, Lundstrom K, Andersson L (1999) A paternally expressed QTL affecting skeletal and cardiac muscle mass in pigs maps to the IGF2 locus. Nat Genet 21:157–158PubMedCrossRefGoogle Scholar
  96. Jones BK, Monks BR, Liebhaber SA, Cooke NE (1995) The human growth hormone gene is regulated by a multicomponent locus control region. Mol Cell Biol 15:7010–7021PubMedGoogle Scholar
  97. Jones BK, Levorse J, Tilghman SM (2001) Deletion of a nuclease-sensitive region between the Igf2 and H19 genes leads to Igf2 misregulation and increased adiposity. Hum Mol Genet 10:807–814PubMedCrossRefGoogle Scholar
  98. Jorge AA, Marchisotti FG, Montenegro LR, Carvalho LR, Mendonca BB, Arnhold IJ (2006) Growth hormone (GH) pharmacogenetics: influence of GH receptor exon 3 retention or deletion on first-year growth response and final height in patients with severe GH deficiency. J Clin Endocrinol Metab 91:1076–1080PubMedCrossRefGoogle Scholar
  99. Juul A, Scheike T, Davidsen M, Gyllenborg J, Jorgensen T (2002) Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case-control study. Circulation 106:939–944PubMedCrossRefGoogle Scholar
  100. Kawashima Y, Kanzaki S, Yang F, Kinoshita T, Hanaki K, Nagaishi J, Ohtsuka Y, Hisatome I, Ninomoya H, Nanba E, Fukushima T, Takahashi S (2005) Mutation at cleavage site of insulin-like growth factor receptor in a short-stature child born with intrauterine growth retardation. J Clin Endocrinol Metab 90:4679–4687PubMedCrossRefGoogle Scholar
  101. Keavney B, McKenzie CA, Connell JM, Julier C, Ratcliffe PJ, Sobel E, Lathrop M, Farrall M (1998) Measured haplotype analysis of the angiotensin-I converting enzyme gene. Hum Mol Genet 7:1745–1751PubMedCrossRefGoogle Scholar
  102. Kennedy GC, German MS, Rutter WJ (1995) The minisatellite in the diabetes susceptibility locus IDDM2 regulates insulin transcription. Nat Genet 9:293–298PubMedCrossRefGoogle Scholar
  103. Kim YJ, Yoon JH, Kim CY, Kim LH, Park BL, Shin HD, Lee HS (2006) IGF2 polymorphisms are associated with hepatitis B virus clearance and hepatocellular carcinoma. Biochem Biophys Res Commun 346:38–44PubMedCrossRefGoogle Scholar
  104. Kojima M, Hosoda H, Kangawa K (2004) Clinical endocrinology and metabolism. Ghrelin, a novel growth-hormone-releasing and appetite-stimulating peptide from stomach. Best Pract Res Clin Endocrinol Metab 18:517–530PubMedCrossRefGoogle Scholar
  105. Kooijman R (2006) Regulation of apoptosis by insulin-like growth factor (IGF)-I. Cytokine Growth Factor Rev 17:305–323PubMedCrossRefGoogle Scholar
  106. Korbonits M, Gueorguiev M, O’Grady E, Lecoeur C, Swan DC, Mein CA, Weill J, Grossman AB, Froguel P (2002) A variation in the Ghrelin gene increases weight and decreases insulin secretion in tall, obese children. J Clin Endocrinol Metab 87:4005–4008PubMedCrossRefGoogle Scholar
  107. Korovkina VP, England SK (2002) Detection and implications of potassium channel alterations. Vascul Pharmacol 38:3–12PubMedCrossRefGoogle Scholar
  108. Kratzsch J, Wu Z, Kiess W, Dehmel B, Bosse-Henck A, Reuter W, Pflaum CD, Strasburger CJ (2001) The exon 3-retaining and the exon 3-deleted forms of the growth hormone-binding protein (GHBP) in human serum are regulated differently. Clin Endocrinol (Oxf) 54:61–68CrossRefGoogle Scholar
  109. Krawczak M, Chuzhanova NA, Cooper DN (1999) Evolution of the proximal promoter region of the mammalian growth hormone gene. Gene 237:143–151PubMedCrossRefGoogle Scholar
  110. Laban C, Bustin SA, Jenkins PJ (2003) The GH-IGF-I axis and breast cancer. Trends Endocrinol Metab 14:28–34PubMedCrossRefGoogle Scholar
  111. Lamberts SW, van den Beld AW, van der Lely AJ (1997) The endocrinology of aging. Science 278:419–424PubMedCrossRefGoogle Scholar
  112. LeMarchand L, Donlon T, Seifried A, Kaaks R, Rinaldi S, Wilkens LR (2002) Association of a common polymorphism in the human GH1 gene with colorectal neoplasia. J Natl Cancer Inst 94:454–460Google Scholar
  113. Leroith D, Yakar S (2007) Mechanisms of Disease: metabolic effects of growth hormone and insulin-like growth factor 1. Nat Clin Pract Endocrinol Metab 3:302–310PubMedCrossRefGoogle Scholar
  114. Li Q, Li B, Wang X, Leri A, Jana KP, Liu Y, Kajstura J, Baserga R, Anversa P (1997) Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy. J Clin Invest 100:1991–1999PubMedCrossRefGoogle Scholar
  115. Li Y, Ye C, Shi P, Zou XJ, Xiao R, Gong YY, Zhang YP (2005) Independent origin of the growth hormone gene family in New World monkeys and Old World monkeys/hominoids. J Mol Endocrinol 35:399–409PubMedCrossRefGoogle Scholar
  116. Lopez-Bermejo A, Buckway CK, Rosenfeld RG (2000) Genetic defects of the growth hormone-insulin-like growth factor axis. Trends Endocrinol Metab 11:39–49PubMedCrossRefGoogle Scholar
  117. Ma J, Pollak MN, Giovannucci E, Chan JM, Tao Y, Hennekens CH, Stampfer MJ (1999) Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst 91:620–625PubMedCrossRefGoogle Scholar
  118. MacLeod JN, Lee AK, Liebhaber SA, Cooke NE (1992) Developmental control and alternative splicing of the placentally expressed transcripts from the human growth hormone gene cluster. J Biol Chem 267:14219–14226PubMedGoogle Scholar
  119. Martin RM, Holly JM, Davey SG, Gunnell D (2006) Associations of adiposity from childhood into adulthood with insulin resistance and the insulin-like growth factor system: 65-year follow-up of the Boyd Orr Cohort. J Clin Endocrinol Metab 91:3287–3295PubMedCrossRefGoogle Scholar
  120. Mauras N, Haymond MW (2005) Are the metabolic effects of GH and IGF-I separable? Growth Horm IGF Res 15:19–27PubMedCrossRefGoogle Scholar
  121. McLellan AS, Kealey T, Langlands K (2006) An E box in the exon 1 promoter regulates insulin-like growth factor-I expression in differentiating muscle cells. Am J Physiol Cell Physiol 291:C300–C307PubMedCrossRefGoogle Scholar
  122. McNay DE, Turton JP, Kelberman D, Woods KS, Brauner R, Papadimitriou A, Keller E, Keller A, Haufs N, Krude H, Shalet SM, Dattani MT (2007) HESX1 mutations are an uncommon cause of septooptic dysplasia and hypopituitarism. J Clin Endocrinol Metab 92:691–697PubMedCrossRefGoogle Scholar
  123. Meinsma D, Scheper W, Holthuizen PE, Van den Brande JL, Sussenbach JS (1992) Site-specific cleavage of IGF-II mRNAs requires sequence elements from two distinct regions of the IGF-II gene. Nucleic Acids Res 20:5003–5009PubMedCrossRefGoogle Scholar
  124. Meloni R, Albanese V, Ravassard P, Treilhou F, Mallet J (1998) A tetranucleotide polymorphic microsatellite, located in the first intron of the tyrosine hydroxylase gene, acts as a transcription regulatory element in vitro. Hum Mol Genet 7:423–428PubMedCrossRefGoogle Scholar
  125. Messier C, Teutenberg K (2005) The role of insulin, insulin growth factor, and insulin-degrading enzyme in brain aging and Alzheimer’s disease. Neural Plast 12:311–328PubMedCrossRefGoogle Scholar
  126. Millar DS, Lewis MD, Horan M, Newsway V, Easter TE, Gregory JW, Fryklund L, Norin M, Crowne EC, Davies SJ, Edwards P, Kirk J, Waldron K, Smith PJ, Phillips JA III, Scanlon MF, Krawczak M, Cooper DN, Procter AM (2003) Novel mutations of the growth hormone 1 (GH1) gene disclosed by modulation of the clinical selection criteria for individuals with short stature. Hum Mutat 21:424–440PubMedCrossRefGoogle Scholar
  127. Miller KK, Biller BM, Lipman JG, Bradwin G, Rifai N, Klibanski A (2005) Truncal adiposity, relative growth hormone deficiency, and cardiovascular risk. J Clin Endocrinol Metab 90:768–774PubMedCrossRefGoogle Scholar
  128. Misra-Press A, Cooke NE, Liebhaber SA (1994) Complex alternative splicing partially inactivates the human chorionic somatomammotropin-like (hCS-L) gene. J Biol Chem 269:23220–23229PubMedGoogle Scholar
  129. Mittanck DW, Kim SW, Rotwein P (1997) Essential promoter elements are located within the 5’ untranslated region of human insulin-like growth factor-I exon I. Mol Cell Endocrinol 126:153–163PubMedCrossRefGoogle Scholar
  130. Monk D, Sanches R, Arnaud P, Apostolidou S, Hills FA, bu-Amero S, Murrell A, Friess H, Reik W, Stanier P, Constancia M, Moore GE (2006) Imprinting of IGF2 P0 transcript and novel alternatively spliced INS-IGF2 isoforms show differences between mouse and human. Hum Mol Genet 15:1259–1269PubMedCrossRefGoogle Scholar
  131. Moorjani S, Roy M, Torres A, Betard C, Gagne C, Lambert M, Brun D, Davignon J, Lupien P (1993) Mutations of low-density-lipoprotein-receptor gene, variation in plasma cholesterol, and expression of coronary heart disease in homozygous familial hypercholesterolaemia. Lancet 341:1303–1306PubMedCrossRefGoogle Scholar
  132. Murphy CT, McCarroll SA, Bargmann CI, Fraser A, Kamath RS, Ahringer J, Li H, Kenyon C (2003) Genes that act downstream of DAF-16 to influence the lifespan of Caenorhabditis elegans. Nature 424:277–283PubMedCrossRefGoogle Scholar
  133. Murrell A, Heeson S, Bowden L, Constancia M, Dean W, Kelsey G, Reik W (2001) An intragenic methylated region in the imprinted Igf2 gene augments transcription. EMBO Rep 2:1101–1106PubMedCrossRefGoogle Scholar
  134. Murrell A, Heeson S, Cooper WN, Douglas E, Apostolidou S, Moore GE, Maher ER, Reik W (2004a) An association between variants in the IGF2 gene and Beckwith–Wiedemann syndrome: interaction between genotype and epigenotype. Hum Mol Genet 13:247–255PubMedCrossRefGoogle Scholar
  135. Murrell A, Heeson S, Reik W (2004b) Interaction between differentially methylated regions partitions the imprinted genes Igf2 and H19 into parent-specific chromatin loops. Nat Genet 36:889–893PubMedCrossRefGoogle Scholar
  136. National Institute for Clinical Excellence (2003) Human growth hormone (somatropin) in adults with growth hormone deficiency, pp 1–36Google Scholar
  137. Nezer C, Moreau L, Brouwers B, Coppieters W, Detilleux J, Hanset R, Karim L, Kvasz A, Leroy P, Georges M (1999) An imprinted QTL with major effect on muscle mass and fat deposition maps to the IGF2 locus in pigs. Nat Genet 21:155–156PubMedCrossRefGoogle Scholar
  138. Nielsen EM, Hansen L, Lajer M, Andersen KL, Echwald SM, Urhammer SA, Hansen T, Pedersen O (2004) A common polymorphism in the promoter of the IGF-I gene associates with increased fasting serum triglyceride levels in glucose-tolerant subjects. Clin Biochem 37:660–665PubMedCrossRefGoogle Scholar
  139. Niu T, Rosen CJ (2005) The insulin-like growth factor-I gene and osteoporosis: a critical appraisal. Gene 361:38–56PubMedCrossRefGoogle Scholar
  140. Norrelund H (2005) The metabolic role of growth hormone in humans with particular reference to fasting. Growth Horm IGF Res 15:95–122PubMedCrossRefGoogle Scholar
  141. Nyegaard M, Borglum AD, Bruun TG, Collier DA, Russ C, Mors O, Ewald H, Kruse TA (2002) Novel polymorphisms in the somatostatin receptor 5 (SSTR5) gene associated with bipolar affective disorder. Mol Psychiatry 7:745–754PubMedCrossRefGoogle Scholar
  142. O’Dell SD, Day IN (1998) Insulin-like growth factor II (IGF-II). Int J Biochem Cell Biol 30:767–771PubMedCrossRefGoogle Scholar
  143. O’Dell SD, Miller GJ, Cooper JA, Hindmarsh PC, Pringle PJ, Ford H, Humphries SE, Day IN (1997) Apal polymorphism in insulin-like growth factor II (IGF2) gene and weight in middle-aged males. Int J Obes Relat Metab Disord 21:822–825PubMedCrossRefGoogle Scholar
  144. Obermann C, Meyer E, Prager S, Tomiuk J, Wollmann HA, Eggermann T (2004) Searching for genomic variants in IGF2 and CDKN1C in Silver-Russell syndrome patients. Mol Genet Metab 82:246–250PubMedCrossRefGoogle Scholar
  145. Pena-Almazan S, Buchlis J, Miller S, Shine B, MacGillivray M (2001) Linear growth characteristics of congenitally GH-deficient infants from birth to one year of age. J Clin Endocrinol Metab 86:5691–5694PubMedCrossRefGoogle Scholar
  146. Petry CJ, Ong KK, Wingate DL, Brown J, Scott CD, Jones EY, Pembrey ME, Dunger DB (2005) Genetic variation in the type 2 insulin-like growth factor receptor gene and disparity in childhood height. Growth Horm IGF Res 15:363–368PubMedCrossRefGoogle Scholar
  147. Phillips (2005) Growth disorders: hereditary. Encyclopedia of life sciences. Wiley, New York, pp 1–6Google Scholar
  148. Potapov A, Liebich I, Donitz J, Schwarzer K, Sasse N, Schoeps T, Crass T, Wingender E (2006) EndoNet: an information resource about endocrine networks. Nucleic Acids Res 34:D540–D545PubMedCrossRefGoogle Scholar
  149. Poulsen P, Vaag A, Kyvik K, Beck-Nielsen H (2001) Genetic versus environmental aetiology of the metabolic syndrome among male and female twins. Diabetologia 44:537–543PubMedCrossRefGoogle Scholar
  150. Powell-Braxton L, Hollingshead P, Warburton C, Dowd M, Pitts-Meek S, Dalton D, Gillett N, Stewart TA (1993) IGF-I is required for normal embryonic growth in mice. Genes Dev 7:2609–2617PubMedCrossRefGoogle Scholar
  151. Procter AM, Phillips JA III, Cooper DN (1998) The molecular genetics of growth hormone deficiency. Hum Genet 103:255–272PubMedCrossRefGoogle Scholar
  152. Pugliese A, Zeller M, Fernandez A Jr, Zalcberg LJ, Bartlett RJ, Ricordi C, Pietropaolo M, Eisenbarth GS, Bennett ST, Patel DD (1997) The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat Genet 15:293–297PubMedCrossRefGoogle Scholar
  153. Quin JD, Fisher BM, Paterson KR, Inoue A, Beastall GH, MacCuish AC (1991) Acute response to recombinant insulin-like growth factor-I in a patient with Mendenhall’s syndrome. New Eng J Med 323:1425–1426Google Scholar
  154. Raben MS (1958) Treatment of a pituitary dwarf with human growth hormone. J Clin Endocrinol Metab 18:901–903PubMedGoogle Scholar
  155. Randhawa R, Cohen P (2005) The role of the insulin-like growth factor system in prenatal growth. Mol Genet Metab 86:84–90PubMedCrossRefGoogle Scholar
  156. Ranke MB (2005) Insulin-like growth factor-I treatment of growth disorders, diabetes mellitus and insulin resistance. Trends Endocrinol Metab 16:190–197PubMedCrossRefGoogle Scholar
  157. Reik W, Murrell A (2000) Genomic imprinting. Silence across the border. Nature 405:408–409PubMedCrossRefGoogle Scholar
  158. Renehan AG, Zwahlen M, Minder C, O’Dwyer ST, Shalet SM, Egger M (2004) Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 363:1346–1353PubMedCrossRefGoogle Scholar
  159. Rice T, Chagnon YC, Perusse L, Borecki IB, Ukkola O, Rankinen T, Gagnon J, Leon AS, Skinner JS, Wilmore JH, Bouchard C, Rao DC (2002) A genomewide linkage scan for abdominal subcutaneous and visceral fat in black and white families: The HERITAGE Family Study. Diabetes 51:848–855PubMedCrossRefGoogle Scholar
  160. Rietveld I, Janssen JA, van Rossum EF, Houwing-Duistermaat JJ, Rivadeneira F, Hofman A, Pols HA, van Duijn CM, Lamberts SW (2004) A polymorphic CA repeat in the IGF-I gene is associated with gender-specific differences in body height, but has no effect on the secular trend in body height. Clin Endocrinol (Oxf) 61:195–203CrossRefGoogle Scholar
  161. Rimoin, Phillips JA (1996) Genetic disorders of the pituitary gland. In: Rimoin DL, Michael-Connor J, Pyeritz RE (eds) Principles and practice of medical genetics. Churchill Livingstone, New York, pp 1331–1364Google Scholar
  162. Rocheville M, Lange DC, Kumar U, Patel SC, Patel RC, Patel YC (2000) Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity. Science 288:154–157PubMedCrossRefGoogle Scholar
  163. Rodríguez S, Gaunt TR, O’Dell SD, Chen XH, Gu D, Hawe E, Miller GJ, Humphries SE, Day IN (2004) Haplotypic analyses of the IGF2-INS-TH gene cluster in relation to cardiovascular risk traits. Hum Mol Genet 13:715–725PubMedCrossRefGoogle Scholar
  164. Rodríguez S, Gaunt TR, Dennison E, Chen XH, Syddall HE, Phillips DI, Cooper C, Day IN (2006a) Replication of IGF2-INS-TH*5 haplotype effect on obesity in older men and study of related phenotypes. Eur J Hum Genet 14:109–116PubMedGoogle Scholar
  165. Rodríguez S, Huang S, Chen XH, Gaunt TR, Syddall HE, Gilg JA, Miller GJ, Cooper CC, Cook DG, Whincup PH, Day IN (2006b) A study of TH01 and IGF2-INS-TH haplotypes in relation to smoking initiation in three independent surveys. Pharmacogenet Genomics 16:15–23PubMedCrossRefGoogle Scholar
  166. Roelfsema F, Biermasz NR, Veldhuis JD (2002) Pulsatile, nyctohemeral and entropic characteristics of GH secretion in adult GH-deficient patients: selectively decreased pulsatile release and increased secretory disorderliness with preservation of diurnal timing and gender distinctions. Clin Endocrinol (Oxf) 56:79–87CrossRefGoogle Scholar
  167. Rosenfeld RG (2006) Molecular mechanisms of IGF-I deficiency. Horm Res 65(Suppl 1):15–20PubMedCrossRefGoogle Scholar
  168. Rudd MF, Webb EL, Matakidou A, Sellick GS, Williams RD, Bridle H, Eisen T, Houlston RS (2006) Variants in the GH-IGF axis confer susceptibility to lung cancer. Genome Res 16:693–701PubMedCrossRefGoogle Scholar
  169. Rudman D, Feller AG, Nagraj HS, Gergans GA, Lalitha PY, Goldberg AF, Schlenker RA, Cohn L, Rudman IW, Mattson DE (1990) Effects of human growth hormone in men over 60 years old. N Engl J Med 323:1–6PubMedCrossRefGoogle Scholar
  170. Sacca L, Cittadini A, Fazio S (1994) Growth hormone and the heart. Endocr Rev 15:555–573PubMedCrossRefGoogle Scholar
  171. Salemi S, Yousefi S, Lochmatter D, Eble A, Deladoey J, Robinson IC, Simon HU, Mullis PE (2007) Isolated autosomal dominant growth hormone deficiency: stimulating mutant GH-1 gene expression drives GH-1 splice-site selection, cell proliferation, and apoptosis. Endocrinology 148:45–53PubMedCrossRefGoogle Scholar
  172. Salvatori R, Fan X, Phillips JA III, Espigares-Martin R, Martin DL I, Freeman KL, Plotnick L, Al-Ashwal A, Levine MA (2001) Three new mutations in the gene for the growth hormone (gh)-releasing hormone receptor in familial isolated gh deficiency type ib. J Clin Endocrinol Metab 86:273–279PubMedCrossRefGoogle Scholar
  173. Salvioli S, Olivieri F, Marchegiani F, Cardelli M, Santoro A, Bellavista E, Mishto M, Invidia L, Capri M, Valensin S, Sevini F, Cevenini E, Celani L, Lescai F, Gonos E, Caruso C, Paolisso G, De Benedictis G, Monti D, Franceschi C (2006) Genes, ageing and longevity in humans: problems, advantages and perspectives. Free Radic Res 40:1303–1323PubMedCrossRefGoogle Scholar
  174. Sandhu MS (2005) Insulin-like growth factor-I and risk of type 2 diabetes and coronary heart disease: molecular epidemiology. Endocr Dev 9:44–54PubMedGoogle Scholar
  175. Sandhu MS, Heald AH, Gibson JM, Cruickshank JK, Dunger DB, Wareham NJ (2002) Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study. Lancet 359:1740–1745PubMedCrossRefGoogle Scholar
  176. Sandhu MS, Gibson JM, Heald AH, Dunger DB, Wareham NJ (2003) Low circulating IGF-II concentrations predict weight gain and obesity in humans. Diabetes 52:1403–1408PubMedCrossRefGoogle Scholar
  177. Savage MO, Camacho-Hubner C, Dunger DB (2004) Therapeutic applications of the insulin-like growth factors. Growth Horm IGF Res 14:301–308PubMedCrossRefGoogle Scholar
  178. Saxena R, Voight BF, Lyssenko V, Burtt NP, de Bakker PI, Chen H, Roix JJ, Kathiresan S, Hirschhorn JN, Daly MJ, Hughes TE, Groop L, Altshuler D, Almgren P, Florez JC, Meyer J, Ardlie K, Bengtsson K, Isomaa B, Lettre G, Lindblad U, Lyon HN, Melander O, Newton-Cheh C, Nilsson P, Orho-Melander M, Rastam L, Speliotes EK, Taskinen MR, Tuomi T, Guiducci C, Berglund A, Carlson J, Gianniny L, Hackett R, Hall L, Holmkvist J, Laurila E, Sjogren M, Sterner M, Surti A, Svensson M, Svensson M, Tewhey R, Blumenstiel B, Parkin M, DeFelice M, Barry R, Brodeur W, Camarata J, Chia N, Fava M, Gibbons J, Handsaker B, Healy C, Nguyen K, Gates C, Sougnez C, Gage D, Nizzari M, Gabriel SB, Chirn GW, Ma Q, Parikh H, Richardson D, Ricke D, Purcell S (2007) Genome-Wide Association Analysis Identifies Loci for Type 2 Diabetes and Triglyceride Levels. Science. doi: 10.1126/science.1142358
  179. Schousboe K, Willemsen G, Kyvik KO, Mortensen J, Boomsma DI, Cornes BK, Davis CJ, Fagnani C, Hjelmborg J, Kaprio J, De Lange M, Luciano M, Martin NG, Pedersen N, Pietilainen KH, Rissanen A, Saarni S, Sorensen TI, Van Baal GC, Harris JR (2003) Sex differences in heritability of BMI: a comparative study of results from twin studies in eight countries. Twin Res 6:409–421PubMedCrossRefGoogle Scholar
  180. Schrager MA, Roth SM, Ferrell RE, Metter EJ, Russek-Cohen E, Lynch NA, Lindle RS, Hurley BF (2004) Insulin-like growth factor-2 genotype, fat-free mass, and muscle performance across the adult life span. J Appl Physiol 97:2176–2183PubMedCrossRefGoogle Scholar
  181. Schut AF, Janssen JA, Deinum J, Vergeer JM, Hofman A, Lamberts SW, Oostra BA, Pols HA, Witteman JC, van Duijn CM (2003) Polymorphism in the promoter region of the insulin-like growth factor I gene is related to carotid intima-media thickness and aortic pulse wave velocity in subjects with hypertension. Stroke 34:1623–1627PubMedCrossRefGoogle Scholar
  182. Scott LJ, Mohlke KL, Bonnycastle LL, Willer CJ, Li Y, Duren WL, Erdos MR, Stringham HM, Chines PS, Jackson AU, Prokunina-Olsson L, Ding CJ, Swift AJ, Narisu N, Hu T, Pruim R, Xiao R, Li XY, Conneely KN, Riebow NL, Sprau AG, Tong M, White PP, Hetrick KN, Barnhart MW, Bark CW, Goldstein JL, Watkins L, Xiang F, Saramies J, Buchanan TA, Watanabe RM, Valle TT, Kinnunen L, Abecasis GR, Pugh EW, Doheny KF, Bergman RN, Tuomilehto J, Collins FS, Boehnke M (2007) A Genome-Wide Association Study of Type 2 Diabetes in Finns Detects Multiple Susceptibility Variants. Science. doi: 10.1126/science.1142382
  183. Seidel B, Glasow A, Schutt M, Kiess W, Wu Z, Strasburger CJ, Kratzsch J (2003) Association between the GH receptor/exon 3 genotype and the level of exon 3-positive GH-binding protein in human serum. Eur J Endocrinol 148:317–324PubMedCrossRefGoogle Scholar
  184. Semina EV, Reiter R, Leysens NJ, Alward WL, Small KW, Datson NA, Siegel-Bartelt J, Bierke-Nelson D, Bitoun P, Zabel BU, Carey JC, Murray JC (1996) Cloning and characterization of a novel bicoid-related homeobox transcription factor gene, RIEG, involved in Rieger syndrome. Nat Genet 14:392–399PubMedCrossRefGoogle Scholar
  185. Sesti G, Sciacqua A, Cardellini M, Marini MA, Maio R, Vatrano M, Succurro E, Lauro R, Federici M, Perticone F (2005) Plasma concentration of IGF-I is independently associated with insulin sensitivity in subjects with different degrees of glucose tolerance. Diabetes Care 28:120–125PubMedCrossRefGoogle Scholar
  186. Sesti G, Sciacqua A, Scozzafava A, Vatrano M, Angotti E, Ruberto C, Santillo E, Parlato G, Perticone F (2007) Effects of growth hormone and insulin-like growth factor-1 on cardiac hypertrophy of hypertensive patients. J Hypertens 25:471–477PubMedCrossRefGoogle Scholar
  187. Shemer J, Adamo ML, Roberts CT Jr, Leroith D (1992) Tissue-specific transcription start site usage in the leader exons of the rat insulin-like growth factor-I gene: evidence for differential regulation in the developing kidney. Endocrinology 131:2793–2799PubMedCrossRefGoogle Scholar
  188. Shmueli O, Horn-Saban S, Chalifa-Caspi V, Shmoish M, Ophir R, jamin-Rodrig H, Safran M, Domany E, Lancet D (2003) GeneNote: whole genome expression profiles in normal human tissues. C R Biol 326:1067–1072PubMedCrossRefGoogle Scholar
  189. Smith PJ, Spurrell EL, Coakley J, Hinds CJ, Ross RJ, Krainer AR, Chew SL (2002) An exonic splicing enhancer in human IGF-I pre-mRNA mediates recognition of alternative exon 5 by the serine-arginine protein splicing factor-2/alternative splicing factor. Endocrinology 143:146–154PubMedCrossRefGoogle Scholar
  190. Su Y, Liebhaber SA, Cooke NE (2000) The human growth hormone gene cluster locus control region supports position-independent pituitary- and placenta-specific expression in the transgenic mouse. J Biol Chem 275:7902–7909PubMedCrossRefGoogle Scholar
  191. Su AI, Cooke MP, Ching KA, Hakak Y, Walker JR, Wiltshire T, Orth AP, Vega RG, Sapinoso LM, Moqrich A, Patapoutian A, Hampton GM, Schultz PG, Hogenesch JB (2002) Large-scale analysis of the human and mouse transcriptomes. Proc Natl Acad Sci USA 99:4465–4470PubMedCrossRefGoogle Scholar
  192. Sun G, Gagnon J, Chagnon YC, Perusse L, Despres JP, Leon AS, Wilmore JH, Skinner JS, Borecki I, Rao DC, Bouchard C (1999) Association and linkage between an insulin-like growth factor-1 gene polymorphism and fat free mass in the HERITAGE Family Study. Int J Obes Relat Metab Disord 23:929–935PubMedCrossRefGoogle Scholar
  193. Suviolahti E, Soro-Paavonen A, Silander K, Kilpikari R, Taskinen M, Pajukanta P, Peltonen L (2004) Variants in IGF2-IGF2AS-INS gene cluster on chromosome 11p15 are associated with obesity related traits in Finns. Atheroscler Suppl 5:60CrossRefGoogle Scholar
  194. Svensson J, Bengtsson BA, Taskinen MR, Wiklund O, Johannsson G (2000) A nine-month, placebo-controlled study of the effects of growth hormone treatment on lipoproteins and LDL size in abdominally obese men. Growth Horm IGF Res 10:118–126PubMedCrossRefGoogle Scholar
  195. Sverrisdottir YB, Elam M, Herlitz H, Bengtsson BA, Johannsson G (1998) Intense sympathetic nerve activity in adults with hypopituitarism and untreated growth hormone deficiency. J Clin Endocrinol Metab 83:1881–1885PubMedCrossRefGoogle Scholar
  196. Takahashi Y, Chihara K (1999) Short stature by mutant growth hormones. Growth Horm IGF Res 9(Suppl B):37–40PubMedCrossRefGoogle Scholar
  197. Takaya K, Ariyasu H, Kanamoto N, Iwakura H, Yoshimoto A, Harada M, Mori K, Komatsu Y, Usui T, Shimatsu A, Ogawa Y, Hosoda K, Akamizu T, Kojima M, Kangawa K, Nakao K (2000) Ghrelin strongly stimulates growth hormone release in humans. J Clin Endocrinol Metab 85:4908–4911PubMedCrossRefGoogle Scholar
  198. The International HapMap Consortium (2005) A haplotype map of the human genome. Nature 437:1299–1320CrossRefGoogle Scholar
  199. Toniolo P, Bruning PF, Akhmedkhanov A, Bonfrer JM, Koenig KL, Lukanova A, Shore RE, Zeleniuch-Jacquotte A (2000) Serum insulin-like growth factor-I and breast cancer. Int J Cancer 88:828–832PubMedCrossRefGoogle Scholar
  200. Ukkola O, Ravussin E, Jacobson P, Snyder EE, Chagnon M, Sjostrom L, Bouchard C (2001a) Mutations in the preproghrelin/ghrelin gene associated with obesity in humans. J Clin Endocrinol Metab 86:3996–3999PubMedCrossRefGoogle Scholar
  201. Ukkola O, Sun G, Bouchard C (2001b) Insulin-like growth factor 2 (IGF2 ) and IGF-binding protein 1 (IGFBP1) gene variants are associated with overfeeding-induced metabolic changes. Diabetologia 44:2231–2236PubMedCrossRefGoogle Scholar
  202. Vaessen N, Heutink P, Janssen JA, Witteman JC, Testers L, Hofman A, Lamberts SW, Oostra BA, Pols HA, van Duijn CM (2001) A polymorphism in the gene for IGF-I: functional properties and risk for type 2 diabetes and myocardial infarction. Diabetes 50:637–642PubMedCrossRefGoogle Scholar
  203. Vaessen N, Janssen JA, Heutink P, Hofman A, Lamberts SW, Oostra BA, Pols HA, van Duijn CM (2002) Association between genetic variation in the gene for insulin-like growth factor-I and low birthweight. Lancet 359:1036–1037PubMedCrossRefGoogle Scholar
  204. Vafiadis P, Bennett ST, Todd JA, Nadeau J, Grabs R, Goodyer CG, Wickramasinghe S, Colle E, Polychronakos C (1997) Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nat Genet 15:289–292PubMedCrossRefGoogle Scholar
  205. van Dam PS (2006) Somatropin therapy and cognitive function in adults with growth hormone deficiency: a critical review. Treat Endocrinol 5:159–170PubMedCrossRefGoogle Scholar
  206. van den Berg G, Veldhuis JD, Frolich M, Roelfsema F (1996) An amplitude-specific divergence in the pulsatile mode of growth hormone (GH) secretion underlies the gender difference in mean GH concentrations in men and premenopausal women. J Clin Endocrinol Metab 81:2460–2467PubMedCrossRefGoogle Scholar
  207. van Laere AS, Nguyen M, Braunschweig M, Nezer C, Collette C, Moreau L, Archibald AL, Haley CS, Buys N, Tally M, Andersson G, Georges M, Andersson L (2003) A regulatory mutation in IGF2 causes a major QTL effect on muscle growth in the pig. Nature 425:832–836PubMedCrossRefGoogle Scholar
  208. van Rijn MJ, Slooter AJ, Bos MJ, Catarino CF, Koudstaal PJ, Hofman A, Breteler MM, van Duijn CM (2006) Insulin-like growth factor I promoter polymorphism, risk of stroke, and survival after stroke: the Rotterdam study. J Neurol Neurosurg Psychiatry 77:24–27PubMedCrossRefGoogle Scholar
  209. Villuendas G, Botella-Carretero JI, Lopez-Bermejo A, Gubern C, Ricart W, Fernandez-Real JM, Millan JL, Escobar-Morreale HF (2006) The ACAA-insertion/deletion polymorphism at the 3′ UTR of the IGF-II receptor gene is associated with type 2 diabetes and surrogate markers of insulin resistance. Eur J Endocrinol 155:331–336PubMedCrossRefGoogle Scholar
  210. Wagner JK, Eble A, Cogan JD, Prince MA, Phillips JA III, Mullis PE (1997) Allelic variations in the human growth hormone-1 gene promoter of growth hormone-deficient patients and normal controls. Eur J Endocrinol 137:474–481PubMedCrossRefGoogle Scholar
  211. Wajnrajch MP, Gertner JM, Harbison MD, Chua SC Jr, Leibel RL (1996) Nonsense mutation in the human growth hormone-releasing hormone receptor causes growth failure analogous to the little (lit) mouse. Nat Genet 12:88–90PubMedCrossRefGoogle Scholar
  212. Walenkamp MJ, Karperien M, Pereira AM, Hilhorst-Hofstee Y, van DJ, Chen JW, Mohan S, Denley A, Forbes B, van Duyvenvoorde HA, van Thiel SW, Sluimers CA, Bax JJ, de Laat JA, Breuning MB, Romijn JA, Wit JM (2005) Homozygous and heterozygous expression of a novel insulin-like growth factor-I mutation. J Clin Endocrinol Metab 90:2855–2864PubMedCrossRefGoogle Scholar
  213. Wang G, Yan B, Deng X, Li C, Hu X, Li N (2005) Insulin-like growth factor 2 as a candidate gene influencing growth and carcass traits and its bialleleic expression in chicken. Sci China C Life Sci 48:187–194PubMedCrossRefGoogle Scholar
  214. Woods KA, Camacho-Hubner C, Savage MO, Clark AJ (1996) Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. N Engl J Med 335:1363–1367PubMedCrossRefGoogle Scholar
  215. Wurzel JM, Parks JS, Herd JE, Nielsen PV (1982) A gene deletion is responsible for absence of human chorionic somatomammotropin. DNA 1:251–257PubMedGoogle Scholar
  216. Yang J, Boerm M, McCarty M, Bucana C, Fidler IJ, Zhuang Y, Su B (2000) Mekk3 is essential for early embryonic cardiovascular development. Nat Genet 24:309–313PubMedCrossRefGoogle Scholar
  217. Yang J, Anzo M, Cohen P (2005) Control of aging and longevity by IGF-I signaling. Exp Gerontol 40:867–872PubMedCrossRefGoogle Scholar
  218. Yu H, Spitz MR, Mistry J, Gu J, Hong WK, Wu X (1999) Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis. J Natl Cancer Inst 91:151–156PubMedCrossRefGoogle Scholar
  219. Yuen KC, Dunger DB (2006) Impact of treatment with recombinant human GH and IGF-I on visceral adipose tissue and glucose homeostasis in adults. Growth Horm IGF Res 16(Suppl A):S55–S61PubMedCrossRefGoogle Scholar
  220. Yuen K, Wareham N, Frystyk J, Hennings S, Mitchell J, Fryklund L, Dunger D (2004) Short-term low-dose growth hormone administration in subjects with impaired glucose tolerance and the metabolic syndrome: effects on beta-cell function and post-load glucose tolerance. Eur J Endocrinol 151:39–45PubMedCrossRefGoogle Scholar
  221. Zaina S, Pettersson L, Thomsen AB, Chai CM, Qi Z, Thyberg J, Nilsson J (2003) Shortened life span, bradycardia, and hypotension in mice with targeted expression of an Igf2 transgene in smooth muscle cells. Endocrinology 144:2695–2703PubMedCrossRefGoogle Scholar
  222. Zeggini E, Weedon MN, Lindgren CM, Frayling TM, Elliott KS, Lango H, Timpson NJ, Perry JR, Rayner NW, Freathy RM, Barrett JC, Shields B, Morris AP, Ellard S, Groves CJ, Harries LW, Marchini JL, Owen KR, Knight B, Cardon LR, Walker M, Hitman GA, Morris AD, Doney AS, McCarthy MI, Hattersley AT (2007) Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes. Science. doi: 10.1126/science.1142364
  223. Zhang W, Maniatis N, Rodriguez S, Miller GJ, Day IN, Gaunt TR, Collins A, Morton NE (2006) Refined association mapping for a quantitative trait: weight in the H19-IGF2-INS-TH region. Ann Hum Genet 70:848–856PubMedCrossRefGoogle Scholar
  224. Zhao Z, Tuakli-Wosornu Y, Lagace TA, Kinch L, Grishin NV, Horton JD, Cohen JC, Hobbs HH (2006) Molecular characterization of loss-of-function mutations in PCSK9 and identification of a compound heterozygote. Am J Hum Genet 79:514–523PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • Santiago Rodriguez
    • 1
    Email author
  • Tom R. Gaunt
    • 1
  • Ian N. M. Day
    • 1
  1. 1.Bristol Genetic Epidemiology Laboratories (BGEL) and MRC Centre for Causal Analyses in Translational Epidemiology (CAiTE), Department of Social MedicineUniversity of BristolBristolUK

Personalised recommendations